Bionet Cash Flow-to-Debt Ratio
Bionet cash flow-to-debt ratio. Bionet (1784) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of NT$51.22 Million could theoretically repay 0% of its total liabilities (NT$879.32 Million) in one year. Check Bionet cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bionet (2017–2025)
Cash flow-to-debt ratio of Bionet from 2017 to 2025. Historical debt coverage capacity for Bionet across 9 annual periods. Check 1784 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Bionet Cash Flow-to-Debt Ratio by Year (2017–2025)
Bionet cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Bionet. For the full cash flow conversion analysis, see Bionet cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | NT$148.04 Million | NT$822.58 Million | ▼ -22.5% |
| 2024 | 0.23x | NT$176.49 Million | NT$760.40 Million | ▼ -5.0% |
| 2023 | 0.24x | NT$153.09 Million | NT$626.47 Million | ▲ +32.7% |
| 2022 | 0.18x | NT$94.65 Million | NT$513.97 Million | ▲ +521.3% |
| 2021 | 0.03x | NT$13.88 Million | NT$468.19 Million | ▼ -82.1% |
| 2020 | 0.17x | NT$73.66 Million | NT$445.44 Million | ▲ +2712.1% |
| 2019 | 0.01x | NT$2.67 Million | NT$453.87 Million | ▲ +120.1% |
| 2018 | -0.03x | NT$-12.97 Million | NT$443.09 Million | ▲ +46.7% |
| 2017 | -0.05x | NT$-24.91 Million | NT$453.33 Million | — |